| CAS: | 191217-81-9 |
| MF: | C10H20ClN3OS |
| MW: | 265.8 |
| EINECS: | 687-708-9 |
| Product Categories: | Inhibitors;Pramipexole;191217-81-9 |
| Mol File: | 191217-81-9.mol |
 |
|
| Pramipexole dihydrochloride monohydrate Chemical Properties |
| Melting point | 290 °C(dec.) |
| storage temp. | 2-8°C |
| solubility | Freely soluble in water, soluble in methanol, sparingly soluble or slightly soluble in ethanol (96 per cent), practically insoluble in methylene chloride. |
| form | neat |
| color | White to Almost white |
| Merck | 14,7705 |
| BCS Class | 1 |
| Pramipexole dihydrochloride monohydrate Usage And Synthesis |
| Chemical Properties | White or almost white, crystalline powder. |
| Uses | These Secondary Standards are qualified as Certified Reference Materials. These are suitable for use in several analytical applications including but not limited to pharma release testing, pharma method development for qualitative and quantitative analyses, food and beverage quality control testing, and other calibration requirements. |
| Uses | Antidepressant; antiparkinsonian; antischizophrenic; dopamine agonist. |
| Definition | ChEBI: A hydrate that is the monohydrate of the dihydrochloride salt of pramiprexole. |
| Brand name | Mirapex (Boehringer Ingelheim). |
| General Description | Pramipexole Dihydrochloride is a non-ergot dopamine agonist widely used for the treatment of early and advanced Parkinson′s disease (PD). It is also used to treat restless legs syndrome.
Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards. |
| Clinical Use |
Parkinson’s disease
Symptomatic treatment of restless legs |
| Drug interactions | Potentially hazardous interactions with other drugs
Avoid concomitant use with antipsychotics. |
| Metabolism | Pramipexole undergoes <10% metabolism to inactive metabolites.
More than 90% of a dose is excreted via renal tubular secretion unchanged into the urine. |
Packing &shipping&Payment
Packing:25kg/drum
Shipping:by sea or by air
Payment:T/T,western union,moneygram
Packaging Details drum
Port:Tianjin
Lead Time :
| Quantity(Kilograms) | 1 - 10000 | >10000 |
| Est. Time(days) | 5 | To be negotiated |
Company information
Hebei Mojin Biotechnology Co., Ltd, Our company is a professional in 4'-Methylacetophenone,Levamisole hydrochloride ,N-Methylformamide and other chemical reagents research and development production enterprises. Our business covers more than 30 countries, most of the big customers come from Europe, America and other countries in the world, we can guarantee the quality and price. In recent decades, with the efforts of all employees, we have established many cooperative companies in shandong, henan, guangdong and other places. Our corporate purpose is based on the market, enhance the strength, take the road of scientific and environmental sustainable development, relying on the country. Technology r & d center, increase the investment in r & d, based on the domestic market, expand the international market, manufacturing quality products, sincere service to the society, into a modern, ecological, scientific and technological enterprise world.
Advantage
In stock
Japan
